Research analysts at StockNews.com assumed coverage on shares of National Instruments (NASDAQ:NATI – Get Rating) in a research report issued on Tuesday. The brokerage set a “buy” rating on the technology company’s stock.
Other equities analysts also recently issued reports about the stock. Robert W. Baird downgraded shares of National Instruments from an “outperform” rating to a “neutral” rating and upped their price objective for the company from $50.00 to $55.00 in a research note on Wednesday, February 1st. Morgan Stanley reaffirmed an “overweight” rating and set a $52.00 price target on shares of National Instruments in a research report on Tuesday, January 17th. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $48.33.
National Instruments Trading Up 0.2 %
Shares of NATI stock opened at $52.47 on Tuesday. The business has a 50-day moving average of $51.75 and a 200 day moving average of $44.58. The company has a debt-to-equity ratio of 0.45, a current ratio of 2.08 and a quick ratio of 1.34. National Instruments has a 1-year low of $29.81 and a 1-year high of $55.04. The stock has a market capitalization of $6.90 billion, a PE ratio of 49.97 and a beta of 1.20.
Insider Transactions at National Instruments
In related news, CEO Eric Howard Starkloff sold 2,100 shares of the company’s stock in a transaction on Friday, January 13th. The stock was sold at an average price of $46.86, for a total value of $98,406.00. Following the sale, the chief executive officer now directly owns 283,478 shares of the company’s stock, valued at $13,283,779.08. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. In related news, CEO Eric Howard Starkloff sold 2,100 shares of National Instruments stock in a transaction dated Friday, January 13th. The shares were sold at an average price of $46.86, for a total transaction of $98,406.00. Following the completion of the transaction, the chief executive officer now directly owns 283,478 shares of the company’s stock, valued at approximately $13,283,779.08. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Scott Arthur Rust sold 2,094 shares of the company’s stock in a transaction dated Tuesday, January 31st. The stock was sold at an average price of $54.25, for a total transaction of $113,599.50. Following the completion of the sale, the executive vice president now owns 55,070 shares in the company, valued at approximately $2,987,547.50. The disclosure for this sale can be found here. In the last quarter, insiders sold 41,290 shares of company stock valued at $2,224,644. Corporate insiders own 0.64% of the company’s stock.
Institutional Inflows and Outflows
A number of large investors have recently added to or reduced their stakes in NATI. Advisor Group Holdings Inc. increased its holdings in shares of National Instruments by 4.6% during the first quarter. Advisor Group Holdings Inc. now owns 6,801 shares of the technology company’s stock valued at $269,000 after acquiring an additional 298 shares in the last quarter. JPMorgan Chase & Co. increased its stake in National Instruments by 38.4% during the 1st quarter. JPMorgan Chase & Co. now owns 272,199 shares of the technology company’s stock valued at $11,048,000 after purchasing an additional 75,507 shares in the last quarter. HighTower Advisors LLC raised its holdings in National Instruments by 3.6% in the first quarter. HighTower Advisors LLC now owns 15,424 shares of the technology company’s stock worth $633,000 after buying an additional 540 shares during the last quarter. Natixis Advisors L.P. lifted its stake in shares of National Instruments by 52.6% in the first quarter. Natixis Advisors L.P. now owns 50,715 shares of the technology company’s stock worth $2,059,000 after buying an additional 17,474 shares in the last quarter. Finally, MetLife Investment Management LLC grew its holdings in shares of National Instruments by 33.5% during the first quarter. MetLife Investment Management LLC now owns 85,304 shares of the technology company’s stock valued at $3,462,000 after buying an additional 21,393 shares during the last quarter. Hedge funds and other institutional investors own 90.87% of the company’s stock.
About National Instruments
National Instruments Corp. engages in the design, manufacture, and sale of systems to engineers and scientists that accelerate productivity, innovation, and discovery. The firm’s products include Labview, TestStand, FlexLogger, Voltage, Temperature, Software Defined Radios, Power Accessories, and Repair Services.
See Also
- Get a free copy of the StockNews.com research report on National Instruments (NATI)
- This Is Why Penny Stock GreenPower Motor Company Is A Win
- Comcast Sum of All Parts is Producing a Cumulative Effect
- The Greenbrier Companies: All Aboard For High-Yield In 2023
- Coty Stock is on the Comeback Trail
- Is Halliburton Stock a Value or a Value Trap?
Receive News & Ratings for National Instruments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Instruments and related companies with MarketBeat.com's FREE daily email newsletter.